Gao Z, Mansor M, Howard F, MacInnes J, Zhao X, Muthana M
Nanomaterials (Basel). 2025; 15(3).
PMID: 39940197
PMC: 11820260.
DOI: 10.3390/nano15030221.
Tang M, Yang Z, Tang X, Ma H, Xie B, Xu J
J Am Chem Soc. 2025; 147(4):3488-3499.
PMID: 39805045
PMC: 11783515.
DOI: 10.1021/jacs.4c14847.
Wang X, Peng J, Meng C, Feng F
Chem Sci. 2024; 15(31):12234-12257.
PMID: 39118629
PMC: 11304552.
DOI: 10.1039/d3sc07006a.
Zhang Q, Le T, Zhao S, Shang C, Hu M, Zhang S
Nanomaterials (Basel). 2024; 14(13).
PMID: 38998730
PMC: 11243741.
DOI: 10.3390/nano14131126.
Wei W, Lu P
Materials (Basel). 2024; 17(13).
PMID: 38998154
PMC: 11242594.
DOI: 10.3390/ma17133070.
Investigation of artificial cells containing the Par system for bacterial plasmid segregation and inheritance mimicry.
Zhao J, Han X
Nat Commun. 2024; 15(1):4956.
PMID: 38858376
PMC: 11164925.
DOI: 10.1038/s41467-024-49412-9.
Engineering HO Self-Supplying Platform for Xdynamic Therapies via Ru-Cu Peroxide Nanocarrier: Tumor Microenvironment-Mediated Synergistic Therapy.
Dirersa W, Kan T, Chang J, Getachew G, Ochirbat S, Kizhepat S
ACS Appl Mater Interfaces. 2024; 16(19):24172-24190.
PMID: 38688027
PMC: 11103653.
DOI: 10.1021/acsami.3c18888.
Putting Hybrid Nanomaterials to Work for Biomedical Applications.
Zhang D, Chen Y, Hao M, Xia Y
Angew Chem Int Ed Engl. 2024; 63(16):e202319567.
PMID: 38429227
PMC: 11478030.
DOI: 10.1002/anie.202319567.
Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.
Wu X, Zhou Z, Li K, Liu S
Adv Sci (Weinh). 2024; 11(16):e2308632.
PMID: 38380505
PMC: 11040387.
DOI: 10.1002/advs.202308632.
Low-temperature photothermal-induced alkyl radical release facilitates dihydroartemisinin-triggered "valve-off" starvation therapy.
Su X, Ouyang B, Liu Y, Wang Y, Xu R, Niu L
Asian J Pharm Sci. 2023; 18(5):100850.
PMID: 37920651
PMC: 10618705.
DOI: 10.1016/j.ajps.2023.100850.
Advanced Phase Change Materials from Natural Perspectives: Structural Design and Functional Applications.
Liu L, Zhang Y, Zhang S, Tang B
Adv Sci (Weinh). 2023; 10(22):e2207652.
PMID: 37226721
PMC: 10401154.
DOI: 10.1002/advs.202207652.
Tunable Nanoparticles with Aggregation-Induced Emission Heater for Precise Synergistic Photothermal and Thermodynamic Oral Cancer Therapy of Patient-Derived Tumor Xenograft.
Zhang L, Chu C, Lin X, Sun R, Li Z, Chen S
Adv Sci (Weinh). 2023; 10(17):e2205780.
PMID: 37078783
PMC: 10265040.
DOI: 10.1002/advs.202205780.
Galvanic Replacement Synthesis of Metal Nanostructures: Bridging the Gap between Chemical and Electrochemical Approaches.
Cheng H, Wang C, Qin D, Xia Y
Acc Chem Res. 2023; 56(7):900-909.
PMID: 36966410
PMC: 10077583.
DOI: 10.1021/acs.accounts.3c00067.
High Electrochemiluminescence from Ru(bpy) Embedded Metal-Organic Frameworks to Visualize Single Molecule Movement at the Cellular Membrane.
Li B, Huang X, Lu Y, Fan Z, Li B, Jiang D
Adv Sci (Weinh). 2022; 9(35):e2204715.
PMID: 36328787
PMC: 9762315.
DOI: 10.1002/advs.202204715.
On-Demand Release of Fucoidan from a Multilayered Nanofiber Patch for the Killing of Oral Squamous Cancer Cells and Promotion of Epithelial Regeneration.
Liu Y, Xu Y, Zhang X, Liu N, Cong B, Sun Y
J Funct Biomater. 2022; 13(4).
PMID: 36278636
PMC: 9589995.
DOI: 10.3390/jfb13040167.
Phase-change composite filled natural nanotubes in hydrogel promote wound healing under photothermally triggered drug release.
Ye J, Li L, Hao R, Gong M, Wang T, Song J
Bioact Mater. 2022; 21:284-298.
PMID: 36157247
PMC: 9478498.
DOI: 10.1016/j.bioactmat.2022.08.026.
Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy.
Ning S, Liu Z, Chen M, Zhu D, Huang Q
Nanoscale Adv. 2022; 4(18):3950-3956.
PMID: 36133353
PMC: 9470029.
DOI: 10.1039/d2na00395c.
Recent advances in phase change material based nanoplatforms for cancer therapy.
Cao C, Yang N, Dai H, Huang H, Song X, Zhang Q
Nanoscale Adv. 2022; 3(1):106-122.
PMID: 36131875
PMC: 9419072.
DOI: 10.1039/d0na00622j.
Stimuli-Responsive Gold Nanocages for Cancer Diagnosis and Treatment.
Li C, Zhao T, Li L, Hu X, Li C, Chen W
Pharmaceutics. 2022; 14(7).
PMID: 35890217
PMC: 9318695.
DOI: 10.3390/pharmaceutics14071321.
Cetyltrimethylammonium chloride-loaded mesoporous silica nanoparticles as a mitochondrion-targeting agent for tumor therapy.
Tang M, Zhang P, Liu J, Long Y, Cheng Y, Zheng H
RSC Adv. 2022; 10(29):17050-17057.
PMID: 35496920
PMC: 9053164.
DOI: 10.1039/d0ra02023k.